| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

and
Anna Senik1,3,
*
INSERM U542, Hôpital Paul Brousse, Villejuif, France,1 URA CNRS 1930, Institut Pasteur, Paris, France,2 Unité INSERM 841, Creteil, France3
Received 21 March 2007/ Accepted 21 July 2007
Primary CD4+ T lymphocytes, supporting in vitro human immunodeficiency virus type 1 (HIV-1) replication, are destined to die by apoptosis. We explored the initial molecular events that act upstream from mitochondrial dysfunction in CD4+ T lymphocytes exposed to the HIV-1LAI strain. We tracked by immunofluorescence the cells expressing the p24 viral antigen and used Percoll density gradients to isolate a nonapoptotic CD4+ T-cell subset with a high inner mitochondrial transmembrane potential (
m) but no outer mitochondrial membrane (OMM) rupture. In most p24+ (but not bystander p24–) cells of this subset, the lysosomes were undergoing limited membrane permeabilization, allowing the lysosomal efflux of cathepsins (Cat) to the cytosol. This was also induced by HIV-1 isolates from infected patients. Using pepstatin A to inhibit Cat-D enzymatic activity and Cat-D small interfering RNA to silence the Cat-D gene, we demonstrate that once released into the cytosol, Cat-D induces the conformational change of Bax and its insertion into the OMM. Inhibition of Cat-D activity/expression also conferred a transient survival advantage upon productively HIV-1-infected cells, indicating that Cat-D is an early death factor. The transfection of activated CD4+ T lymphocytes with a Nef expression vector rapidly induced the permeabilization of lysosomes and the release of Cat-D, with these two events preceding OMM rupture. These results reveal a previously undocumented mechanism in which Nef acts as an internal cytopathic factor and strongly suggest that this viral protein may behave similarly in the context of productive HIV-1 infection in CD4+ T lymphocytes.
Published ahead of print on 1 August 2007.
J.E. and A.S. contributed equally to this work.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|